◀  Back to Library


Ms Robin Hansen, Director

Ms Robin Hansen

Molecule2Market (M2M) is a boutique Australian CRO. Co-founder and Director of M2M, Robin leads a highly experienced team of clinical research professionals dedicated to advancing the research and development of innovative medical treatments. Combining our expertise and experience, we provide high quality services across all phases of clinical research and a broad range of therapeutic areas.

Molecule2market Clinical Trial Site

M2M offers the simplicity of support through one organization, and can assist with clinical, regulatory, quality assurance/audit, data management/statistics, medical monitoring and local sponsorship services (including guidance on leverage the Australian R&D tax incentive).

View Company Profile